HB Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
HB Wealth Management's BMY Position: Q2 2026 in Review
HB Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, selling an estimated $176K and leaving 106,923 shares worth $6.16M. The position accounts for 0.03% of the portfolio, ranked #243.
HB Wealth Management first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.67M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- HB Wealth Management held 106,923 shares of Bristol-Myers Squibb worth $6.16M as of Q2 2026.
- HB Wealth Management sold 3,070 Bristol-Myers Squibb shares in Q2 2026, an estimated $176K.
- Bristol-Myers Squibb made up 0.03% of HB Wealth Management's portfolio in Q2 2026, its #243 holding.
- HB Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- HB Wealth Management's Bristol-Myers Squibb position peaked at $6.67M in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.